Reprint

Age-Related Macular Degeneration and Diabetic Retinopathy

Edited by
May 2022
228 pages
  • ISBN978-3-0365-4210-2 (Hardback)
  • ISBN978-3-0365-4209-6 (PDF)

This book is a reprint of the Special Issue Age-Related Macular Degeneration and Diabetic Retinopathy that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

This reprint includes contributions from leaders in the field of personalized medicine in ophthalmology. The contributions are diverse and cover pre-clinical and clinical topics. We hope you enjoy reading the articles.

Format
  • Hardback
License
© by the authors
Keywords
subthreshold micropulse laser; 577-nm laser; laser fixed parameters; diabetic retinopathy; diabetic macular edema; optical coherence tomography; autofluorescence; real-life; diabetic retinopathy; diabetic macular oedema; visual prognosis; indicators; personalized medicine; age-related macular degeneration; choroidal neovascularization; classification; machine learning; optical coherence tomography; type 2 diabetes; retinopathy; ethnicity; general practice; risk factors; diabetic retinopathy; type 2 diabetes; progression; glycemic gap; glucose variability; diabetic retinopathy; ETDRS classification; biomarkers; visual prognosis; phenotypes; personalized medicine; diabetic retinopathy; anti-vascular endothelial growth factor; diabetic retinopathy severity scale; panretinal leakage index; neovascular age-related macular degeneration; anti-VEGF therapy; optical coherence tomography; retinal thickness; visual acuity; variability; anti-vascular endothelial growth factor; diabetic macular edema; diabetic retinopathy; leakage index; microaneurysms; intravitreal aflibercept; neovascularization; optical coherence tomography; ultra-widefield fluorescein angiography; retinal imaging; quantitative biomarkers; diabetic retinopathy; diabetic macular edema; age-related macular degeneration; precision medicine; anti-VEGF therapy; autoantibodies; age-related macular degeneration; biomarkers; AT1-receptor; PAR1; VEGF-A; VEGF-B; VEGF-receptor 2; age-related macular degeneration; AMD; complement system; semi-quantitative multiplex profilin; mass spectrometry; C4; vitronectin; factor I; genetic variants; metabolites; HDL; diabetic macular edema; visual acuity; central area thickness; biomarker; microRNA; anti-VEGF; diabetic retinopathy; retina; edema; OCT; tomography; microphysiological systems; blood-neural barriers; neurovascular unit; disease modeling; 3D models; organ-on-a-chip; inner blood-retinal barrier; n/a